Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.8%

1 terminated out of 36 trials

Success Rate

95.8%

+9.3% vs benchmark

Late-Stage Pipeline

25%

9 trials in Phase 3/4

Results Transparency

4%

1 of 23 completed with results

Key Signals

1 with results96% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (3)
Early P 1 (1)
P 1 (20)
P 2 (2)
P 3 (5)
P 4 (4)

Trial Status

Completed23
Unknown9
Not Yet Recruiting1
Terminated1
Active Not Recruiting1
Recruiting1

Trial Success Rate

95.8%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT06573489Phase 4RecruitingPrimary

Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical Trial

NCT06889376Phase 1Not Yet RecruitingPrimary

Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination.

NCT01722916Early Phase 1Active Not RecruitingPrimary

Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

NCT06644105Not ApplicableCompleted

Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women

NCT01669824Completed

Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg

NCT04785027Phase 1Unknown

Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis

NCT01367873Phase 1CompletedPrimary

Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects

NCT05921006Phase 1UnknownPrimary

Ascending Single-Dose and Multiple-Dose Study to Evaluate RJ4287 in Healthy Subjects

NCT01179854Phase 2CompletedPrimary

Remegal Different Doses in Patients With Refractory Partial Seizures

NCT00376415Phase 1CompletedPrimary

A Safety Study of Lessertia Frutescens in Adults.

NCT01425502Not ApplicableCompletedPrimary

Data-driven Quality Improvement in Primary Care - Trial

NCT01727778Phase 1CompletedPrimary

Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma

NCT02202603Phase 1CompletedPrimary

A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects

NCT01847222Phase 1TerminatedPrimary

An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE™ in Healthy Volunteers.

NCT01475097Phase 4CompletedPrimary

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

NCT01403545Phase 1CompletedPrimary

Evaluation of Liposomal Curcumin in Healthy Volunteers

NCT01740960Phase 1CompletedPrimary

Safety and Tolerability of Namisol in the Elderly

NCT01814280Not ApplicableCompletedPrimary

Reducing Medication Errors on Basis of an Individual Risk Assessment

NCT01648127Phase 1CompletedPrimary

Pharmacokinetics of Ceftaroline in Normal and Obese Subjects

NCT01757860Phase 1CompletedPrimary

Safety and Pharmacokinetics Study of CARD-024 in Healthy Subjects

Scroll to load more

Research Network

Activity Timeline